Beta-blocking drugs competitively inhibit catecholamines by binding to beta receptors. Their clinical importance is influenced by properties like beta 1 selectivity, intrinsic sympathomimetic activity (ISA), and lipophilicity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: